Answers are grounded in this paper and cite their sources.
The fact that bronchogenic carcinoma can seldom, if ever, be cured by irradiation has rarely been disputed. There are many factors which account for the failure of radiation to cure carcinoma of the lung. The most important of these are as follows: 1. Bronchogenic carcinoma is usually invasive by nature, and, because it is growing in an organ which is extremely vascular, it invades the blood and lymphatic channels early, often producing metastases before detection of the primary tumor. 2. Bronchogenic carcinomas are generally radioresistant. Undifferentiated carcinomas often have been classified erroneously as radiosensitive tumors. They are more correctly classified as radio-responsive, since they respond promptly but usually have invaded the blood and lymphatic channels before they are controlled locally, and thus are never cured. 3. Patients with bronchogenic cancer have often so deteriorated before the diagnosis is made that they are unable to tolerate cancerocidal tumor doses. 4. The lung tolerates radiation poorly, and a tumor dose which is cancerocidal for a pulmonary neoplasm is often sufficiently high to produce irreparable damage to the normal tissues overlying and surrounding it. Since the nature of the disease and the bed in which the tumor is growing cannot be altered by any means at present at our disposal, the only hope of improving the results of treatment in bronchogenic carcinoma lies in an attempt to deliver a cancerocidal dose to the neoplasm without producing critical damage to the surrounding tissues and to the host himself. Cobalt teletherapy and supervoltage x-ray therapy have a better chance of accomplishing this than radiation of lower energy. Percentagewise, the improvement in statistics thus attained would be small, since treatment failures are seldom due to insufficient dose alone. Any improvement, however, is significant, considering the hopelessness of inoperable carcinoma of the lung at the present time. In 1956, the writer of this paper compiled statistics on all patients receiving 400-kv x-ray therapy for bronchogenic carcinoma between March 1, 1952, and March 1, 1955, in the Radiation Therapy Department of Allegheny General Hospital. These statistics have been reported elsewhere (8). In summary, 50 histologically proved cases were reported. Twenty patients had lesions which were undifferentiated, 18 had well differentiated squamous-cell lesions, 9 histologically proved malignant tumors of unknown cell type, and 3 adenocarcinomas. Analysis of the undifferentiated group showed an average survival time of only 4.7 months, and no patient lived as long as a year following the initiation of x-ray therapy. The squamous-cell group, comprising 18 patients, had an average survival time of 11.4 months at the time of the report, and 53 per cent of the patients had lived over one year.
No takes yet. Share an insight, caveat, or question.
Eugene R. Kutz (1958) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: